Abdulrahman Nasiri: Alloimmune Thrombocytopenia After Liver Transplantation from Donor with ITP
Abdulrahman Nasiri, Assistant Professor of Medicine and Hematology at Imam Mohammad Ibn Saud Islamic University, shared on LinkedIn:
”I am pleased to share the publication of our recent case report in Hematology:
“Transplantation-mediated alloimmune thrombocytopenia following liver transplantation from a donor with ITP: a case report and review of the literature.”
This report describes a rare but serious complication of liver transplantation, where donor derived immune cells caused profound thrombocytopenia in the recipient.
Our case highlights that intensive medical therapy alone can achieve full recovery and avoid the need for retransplantation, an important insight for transplant teams worldwide.
I am deeply grateful to my colleagues for their dedication and to Dr. Hazzaa Alzahrani for his invaluable guidance and supervision throughout this work.”
Read the full article here.
Article: Transplantation-mediated alloimmune thrombocytopenia following liver transplantation from a donor with ITP: a case report and review of the literature
Authors: Ahmed Bin Salman, Mostafa F. Mohammed Saleh, Abdulrahman Nasiri, Hazza Alzahran

Stay informed on the latest scientific advances in the field of platelet disorders with Hemostasis Today.
-
Feb 12, 2026, 16:36Tagreed Alkaltham: Tranexamic Acid in PBM
-
Feb 12, 2026, 16:35Paul Lambis Announces Maria Hadjidemetriou as a Speaker at Cyprus Diaspora Forum
-
Feb 12, 2026, 16:34Rahul Bhargava: Breaking Myths About Bone Marrow Transplant
-
Feb 12, 2026, 16:29Arun V J: Can You Be A Doctor And Still Be Stupid?
-
Feb 12, 2026, 16:26Changing the Narrative Around PPH – End Postpartum Hemorrhage
-
Feb 12, 2026, 16:20Mahesan Subramaniam: The Protective Switch in Brain Immune Cells Could Slow Alzheimer’s Disease
-
Feb 12, 2026, 16:13Lale Tokgözoğlu: Top 10 Dyslipidemia Papers of 2025
-
Feb 12, 2026, 16:10Neelam Mohan: Breaking Down Anemia from Causes and Testing to Treatment and Prevention
-
Feb 12, 2026, 16:04Irma Bagdoniene: From Estimating Risk to Seeing Disease in Preventive Cardiology